COMMENTARY ARTICLE
AI-driven strategies, which have emerged in diverse high-tech fields over the past few years, are now reshaping supply chains in pharmaceuticals, healthcare, chemicals, and biotechnology by placing sustainability and human well-being at the forefront. Over the course of the early twenty-first century, rapid strides in data-centric technologies and refined metrics for environmental, social, and governance (ESG) considerations have opened up new possibilities for optimizing everything from R&D processes to large-scale manufacturing and global distribution. The pages that follow offer cross-industry perspectives through different panel discussions on how AI and ESG principles are evolving, and how they might define the future of sustainable operations across various sectors.
Login now to read the full article
Don’t have an account yet? Subscribe now, it’s free!
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt.
All pubblications
archive from 2022 to today
All articles
PDF Version
Receive our latest issue alerts
directly to your mailbox
